SIGN UP

top stories

Sarepta licenses Arrowhead's RNA-based rare disease pipeline, promising big biobucks

10 hours ago

Updated: Amgen obesity shot shows 20% weight loss, but dosing questions hang over readout

14 hours ago

Food allergy biotech Alladapt closes after Phase 3 talks with FDA

10 hours ago

Latest

Most read

The Biden administration wants Medicare and Medicaid to cover GLP-1s. Will the Trump White House allow it?

5 hours ago

Axsome moves toward NDA filing for narcolepsy drug following positive Phase 3 data

8 hours ago

Soleno’s rare pediatric disease drug faces PDUFA delay by three months

10 hours ago

Agilent reveals plans to remodel operations as annual revenue dips

10 hours ago

see latest stream

People

For CDC, Trump picks Dave Weldon, a former congressman who pushed for vaccine injury claims

3 days ago

Trump taps Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, surgeon general picks

4 days ago

Lexicon ends commercial work to focus on R&D

4 days ago

Financing

Why Morgan Health is backing an autism care company

Yesterday

ADC biotech Adcendo nabs $135M Series B as it enters the clinic

Yesterday

Microsoft-backed Enveda raises $130M for drugs in I&I, obesity and other areas

5 days ago

Startups

Gilead buys experimental HIV vaccines from a small Barcelona biotech

Yesterday

Venrock adds $500M to healthcare investing strategy after outlining 10th fund in January

6 days ago

Carolyn Bertozzi’s latest biotech debuts with $30M seed round and a sugary spin on immunotherapy

6 days ago

Deals

Updated: Roche buys out CAR-T partner Poseida for $1B upfront

15 hours ago

Cradle Bio raises $73M Series B to sell pharma its protein-making AI software

18 hours ago

Halozyme withdraws Evotec acquisition proposal after biotech is 'unwilling to engage'

4 days ago

In FocusSee all

Lawmakers are poking holes in pharma's favorite new way to market medicines

Last week

A rare neurological disease is Sage’s last, best hope after failures in depression

Last week

Yorvipath’s approval showcases biopharma’s interest in rare endocrine disorder

3 weeks ago

Biotech industry worries over potential for RFK Jr. ally as FDA pick

3 weeks ago

Endpoints Standouts

How the world's biggest pharma and biotech companies paid their typical worker in 2023

4 months ago

In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024

4 months ago

Biopharma leaders charting a path for the industry's LGBTQ+ community

5 months ago

Peter Marks single-handedly approved Sarepta’s gene therapy — what does that mean for everyone else?

5 months ago

Peer review See all

Nov

22

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Nov

15

ALX Oncology hires Genentech, Mirati vet as CMO; After Carmot, Heather Turner has three new roles on tap

Nov

8

Legend names a president of Carvykti; Novo Nordisk's top North America exec is stepping down

Nov

1

Biogen brings in medical chief as CFO plans retirement; MacroGenics CEO announces departure

Oct

25

Chinook alums reunite following exit to Novartis; The first board appointment for Recursion’s Chris Gibson

Pharma channel feed

Yesterday

Bristol Myers reveals more job cuts in New Jersey

Bristol Myers Squibb's cost-cutting initiative will lead to additional layoffs in Lawrenceville, NJ, the company revealed this month in a state WARN notice.

READ MORE

Minnesota 340B revenue driven by hospitals and high-priced drugs, first state report says

Yesterday

Merck halts Phase 3 trial with PAH drug Winrevair following positive interim data

Yesterday

latest in Pharma

AstraZeneca’s Truqap edges closer to prostate cancer label expansion with Phase 3 win

Yesterday

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

4 days ago

Sanofi introduces new 340B payment model — report

4 days ago

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

4 days ago

Senate Judiciary Committee advances patent bill with new protections for pharma challenges

4 days ago

see latest stories

Marketing channel feed

5 days ago

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

As the healthcare priorities of President-elect Donald Trump and his HHS pick Robert F. Kennedy Jr. take shape, one idea gaining steam is a ban on direct-to-consumer pharmaceutical ...

READ MORE

FDA says Merz's social media promotion with Nate Berkus is 'misleading'

Last week

Valneva and Pfizer eye 2027 launch for partnered Lyme disease vaccine

Last month

latest in Marketing

UK watchdog criticizes Moderna for Covid-19 trial's use of WhatsApp to dangle payments to children

2 months ago

FDA criticizes AbbVie's 'misleading' ad with Serena Williams

2 months ago

Updated: Madrigal finally reveals first wave of sales for MASH drug Rezdiffra

3 months ago

RSV market pressure leads to slower launch for Moderna's vaccine

3 months ago

Verona inks financing deal worth up to $650M ahead of COPD decision

6 months ago

see latest stories

FDA+ channel feed

Yesterday

Trump team asked Warp Speed leader to head NIH, may seek more traditional pick for role

The transition team for President-elect Donald Trump was still searching for its next National Institutes of Health director as recently as last week, multiple sources told Endpoints News, ...

READ MORE

FDA adcomm raises risk questions on AstraZeneca’s Andexxa

5 days ago

Jazz wins approval for bispecific in biliary tract cancer

5 days ago

latest in FDA+

FDA updates label of 33-year-old cancer drug with new dose and warning

6 days ago

When generative AI meets the FDA: First digital health adcomm kicks off discussion

6 days ago

GSK plots regulatory filings for PBC itch after positive Phase 3 readout

Last week

FDA rejects Astellas’ effort to support longer use of eye drug Izervay

Last week

Ahead of adcomm, FDA raises safety questions for AstraZeneca’s reversal agent for life-threatening bleeds

Last week

see latest stories

Manufacturing channel feed

5 days ago

At Jefferies, all that manufacturers want to talk about is GLP-1s

LONDON — Thousands of delegates flooded into the narrow corridors of the Waldorf Hilton this week to attend the Jefferies London Healthcare Conference. It was so busy that at one point, ...

READ MORE

Samsung Bio's new $668M client; Sanofi expands a factory in France

5 days ago

Chinese drugmaker receives FDA warning letter after management hindered inspection

Last week

latest in Manufacturing

Evotec gains on Halozyme's takeover proposal

Last week

European Commission seeks biopharma feedback on Novo-Catalent deal — report

Last week

Lonza expands bioconjugates factory; WuXi Bio adds capacity in Germany

Last week

Novo Nordisk to phase out its production of human insulin pens globally

Last week

Merck KGaA’s life science unit is still feeling the Covid demand decline

Last week

see latest stories